Predictive Model for Mortality in Older People With Critical Illness
Launched by CONSORCI SANITARI DE L'ALT PENEDÈS I GARRAF · Dec 10, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing a model to help predict which older patients are most at risk of dying after being admitted to an intensive care unit (ICU) due to critical illness. The goal is to identify these patients quickly, so that healthcare providers can make informed decisions about their care.
To be eligible for this study, participants must be 75 years old or older and must come to the ICU directly from the Emergency Department. They will need to provide consent for participation, either themselves or through a legal representative. However, patients who are transferred from another hospital ward, who die within the first 24 hours of ICU admission, or who have certain serious medical conditions will not be included in the study. Since the trial is not yet recruiting, there is no immediate action required, but it aims to help improve understanding and treatment for older adults facing critical health issues in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women aged 75 or older.
- • Admission to an ICU from the Emergency Department.
- • Availability of or possibility to contact a participant's informant.
- • Informed consent for participation in the study, either by the participant or a valid legal representative.
- Exclusion Criteria:
- Participants meeting any of the following exclusion criteria will not be included in the study:
- • Patients transferred to the Emergency Department from a hospital ward.
- • Patients who die within the first 24 hours of ICU admission.
- • Patients admitted to Step-Down Units.
- * Patients requiring ICU admission for any of the following reasons:
- • Orotracheal intubation or advanced cardiopulmonary resuscitation performed prior to arrival at the Emergency Department.
- • AV block awaiting pacemaker implantation. Activation of the STEMI or Stroke care pathway. Post-cardiac catheterization for acute coronary syndrome.
- • Participation in another clinical study involving an intervention, procedure, or visit schedule that is incompatible with the present study.
About Consorci Sanitari De L'alt Penedès I Garraf
Consorci Sanitari de l'Alt Penedès i Garraf is a leading healthcare consortium located in Catalonia, Spain, dedicated to providing high-quality medical services and advancing clinical research. With a commitment to innovation and patient-centered care, the consortium integrates various health services, including hospitals and specialized care facilities, to enhance health outcomes in the Alt Penedès and Garraf regions. By fostering collaboration among healthcare professionals and engaging in clinical trials, the consortium aims to contribute to the development of new therapies and improve the overall healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Barcelona, Cataluña, Spain
Barcelona, Cataluña, Spain
Barcelona, , Spain
Badalona, Barcelona, Spain
Barcelona, , Spain
Barcelona, , Spain
Girona, , Spain
Girona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Sant Pere De Ribes, Barcelona, Spain
Barcelona, , Spain
Barcelona, , Spain
Girona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported